Trial
NCT04111107
Precision Medicine for Patients With Identified Actionable Mutations
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
National Cancer Institute (NCI)
Condition
Solid Tumor
Intervention
Investigational Agent
Why stopped
PI left the institution and site decided not to continue the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-03